Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
01/08/1992 | EP0465081A1 Viral decoy vaccine |
01/08/1992 | EP0464727A2 Use of a composition for the preparation of a medicament for debridment of retained lens material |
01/08/1992 | EP0464573A1 Plaster high in softening substances |
01/08/1992 | EP0464274A1 Soft gelatin capsule |
01/08/1992 | EP0464163A1 Use of supercritical fluids to obtain porous sponges of biodegradable polymers. |
01/08/1992 | EP0464135A1 Method for reducing side effects of a drug. |
01/08/1992 | EP0464106A1 Device for administering an active agent to the skin or mucosa. |
01/08/1992 | EP0464077A1 Process for the preparation of a ligand-receptor complex. |
01/08/1992 | EP0464023A1 Realease assist microcapsules |
01/08/1992 | EP0352282B1 Paucilamellar lipid vesicles |
01/08/1992 | EP0349579B1 Lipid vesicles formed of surfactants and steroids |
01/08/1992 | EP0160051B1 Foamable biocide composition |
01/07/1992 | US5079261 Use of lipoxin a4 and its derivatives as antagonists for slow-reacting substances of anaphylaxis |
01/07/1992 | US5079253 Composition for the topical treatment of glaucoma or ocular hypertension |
01/07/1992 | US5079018 Readily Dissovable Gelatin Carrier |
01/07/1992 | US5079009 Controlled release compositions including polyethylene oxide with urethane cross-linking |
01/07/1992 | US5079008 Transdermal monolith systems |
01/07/1992 | US5079007 Controlled release of antibiotic salts from an implant |
01/07/1992 | US5079006 Pharmaceutical compositions containing a magnetically detectable material |
01/07/1992 | US5079005 Impregnating Porous Seed Protein Particles With A Pharmaceutical, Cosmetic, Pesticide |
01/07/1992 | US5079001 Liquid oral formulation of diclofenac |
01/07/1992 | US5078997 Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers |
01/07/1992 | US5078994 Microgel drug delivery system |
01/07/1992 | US5078993 Ointment pharmaceutical formulation |
01/07/1992 | CA1293941C Method for preparing antihemophilic factor (ahf) by cold precipitation and for improving solubility of recovered ahf product |
01/07/1992 | CA1293929C Pharmaceutical composition containing nifedipine |
01/07/1992 | CA1293924C Nonirritating teat dip and method |
01/04/1992 | WO1992000718A1 Intragingival delivery systems for treatment of periodontal disease |
01/04/1992 | CA2065156A1 Intragingival delivery systems for treatment of periodontal disease |
01/04/1992 | CA2046079A1 Pharmaceutical compositions and methods for alleviating gastrointestinal distress symptoms induced by nonsteroidal anti-inflammatory drugs |
01/03/1992 | WO1992000064A1 Process for producing pressed, moulded, delayed release dose units and dose units thus produced |
01/02/1992 | EP0463962A1 Preparation of fatty product microspheres loaded or not with an active substance |
01/02/1992 | EP0463877A1 Controlled release pharmaceutical preparation |
01/02/1992 | EP0463833A2 Controlled release pharmaceutical preparation and process for preparing same |
01/02/1992 | EP0463653A1 Galenic formulations containing cyclodextrins |
01/02/1992 | EP0463454A2 Transdermal administration to humans and animals |
01/02/1992 | EP0463268A1 Flexible sealed radioactive film for radiotherapy, and method of making same |
01/02/1992 | EP0463228A2 Injectable formulations containing the sodium salt of naproxen |
01/02/1992 | EP0463194A1 Process for the preparation of poly(D,L-lactide) and its use as a drug carrier |
01/02/1992 | EP0463126A1 Methods of enhancing wound healing and tissue repair |
01/02/1992 | EP0451299A4 Magnetocontrollable carrier with physiologically active substance and method for making said carrier |
01/02/1992 | EP0177573B1 Biodegradable matrix and methods for producing same |
01/02/1992 | DE4021050A1 Microcapsules prepn. with liq. nucleus and semipermeable membrane - by adding droplets of heterogeneously prepd. sodium cellulose sulphate soln. to pptn. bath contg. poly:di:methyl di:allyl ammonium chloride |
01/02/1992 | DE4021047A1 Biodegradable homo- and co-polyester(s) of aliphatic hydroxy-carboxyli - Homo- and co-polyester(s) of aliphatic hydroxy-carboxylic acids |
01/01/1992 | CN1015229B Process of preparation for blood vessel thrombotic agent (th glue) |
01/01/1992 | CN1015228B Smoking article with fuel element |
12/31/1991 | US5077310 Granulation product of calcium ascorbate |
12/31/1991 | US5077296 Method for treating equine navicular disease with pentoxifylline, and composition containing pentoxifylline for administrating to horses |
12/31/1991 | US5077241 Sol gel-derived ceramic bubbles |
12/31/1991 | US5077211 Purification and administration of dna repair enzymes |
12/31/1991 | US5077104 Nicotine packaging materials |
12/31/1991 | US5077058 Microspheres impregnated with a drug or cosmetic |
12/31/1991 | US5077057 Preparation of liposome and lipid complex compositions |
12/31/1991 | US5077056 Encapsulation of antineoplastic agents in liposomes |
12/31/1991 | US5077055 Topical therapeutic system comprising 5-fluorouracil |
12/31/1991 | US5077054 Prevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug |
12/31/1991 | US5077053 Sorbitol with multiple coating layers |
12/31/1991 | US5077052 Chitosan derivatives useful in compositions for coating feedstuff additives intended for ruminants |
12/31/1991 | US5077051 Sustained release of active agents from bioadhesive microcapsules |
12/31/1991 | US5077049 Placing solution of water coagulable thermoplastic polymer in water miscible nontoxic solvent into periodontal pocket, forming in situ solid porous implant; promotes cell growth |
12/31/1991 | US5077048 Water-soluble polymer, sodium and potassium salt of an organic salts of carboxylic acids, electrolyte balance; shelf life |
12/31/1991 | US5077036 Storage stability |
12/31/1991 | US5077033 Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide |
12/31/1991 | US5076933 Filtration with diethylaminoethyl cellulose filter membrane an d quaternary aminoalkyl salt-coated filters |
12/30/1991 | WO1992000132A1 Process and apparatus for removal of dna and viruses |
12/30/1991 | WO1992000081A1 Vaccine compositions containing liposomes |
12/30/1991 | WO1992000063A1 Method for smoothing granules of active principles |
12/30/1991 | CA2084873A1 Process and apparatus for removal of dna and viruses |
12/30/1991 | CA2064056A1 Process for the smoothing of active ingredient granules |
12/28/1991 | WO1992000062A1 The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations |
12/28/1991 | WO1991016914A1 Methods and preparations of stable, deodorized oils and pharmaceutical compositions thereof |
12/28/1991 | CA2086096A1 Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations |
12/28/1991 | CA2082418A1 Methods and preparations of stable, deodorized oils and pharmaceutical compositions thereof |
12/27/1991 | EP0462959A1 Coated veterinary implants. |
12/27/1991 | EP0462723A1 Easily soluble granules containing a binding agent |
12/27/1991 | EP0462608A1 Implantable drug depot material |
12/27/1991 | EP0462388A2 Coated particles, hollow particles, and process for manufacturing the same |
12/27/1991 | EP0462305A1 Aerosol containing cytokines and use thereof |
12/27/1991 | EP0462110A1 Intrauterine contraceptive device |
12/27/1991 | EP0253901B1 Sustained-release preparation |
12/27/1991 | EP0227836B1 Sustained releasing patch |
12/27/1991 | EP0224545B1 Pharmaceutical depot preparation |
12/27/1991 | CA2045428A1 Method for enhancing the lowering of plasma cholesterol levels |
12/26/1991 | WO1992000140A1 Starch encapsulation of biologically active agents by a continuous process |
12/26/1991 | WO1992000109A1 Bioceramic system for delivery of bioactive compounds |
12/26/1991 | WO1992000066A1 Amantadine hydrochloride suspension with enhanced dissolution characteristics for use in soft gelatin capsules |
12/26/1991 | WO1991019803A1 Self assembled, defective, nonself-propagating viral particles |
12/26/1991 | WO1991019501A1 Intercellular adhesion mediators |
12/26/1991 | WO1991019483A1 Compositions and methods for the controlled release of soluble active substances |
12/26/1991 | WO1991019482A1 Aminosteroids for ophthalmic use |
12/26/1991 | WO1991019481A1 Reversible gelation compositions and methods of use |
12/26/1991 | WO1991019470A1 Polyurethane-biopolymer composite |
12/26/1991 | WO1991016045A3 Use of 5-ht4 receptor antagonists in the treatment of arrythmias and stroke |
12/26/1991 | CA2086095A1 Bioceramic system for delivery of bioactive compounds |
12/26/1991 | CA2085585A1 Amantadine hydrochloride suspension with enhanced dissolution characteristics for use in soft gelatin capsules |
12/25/1991 | CN1057192A Mfg. technology of medicated oil (for rheumatism) polyurethane sponge |
12/24/1991 | US5075314 Prevention nighttime urination in animals |
12/24/1991 | US5075312 Prevention nighttime urination in young animals |
12/24/1991 | US5075295 Novel oxytetracycline compositions |
12/24/1991 | US5075291 Crystalline sugar alcohol containing uniformly dispersed particulate pharmaceutical compound |